首页 › 基金 › ACORN CAPITAL ADVISORS, LLC › ANTX

ACORN CAPITAL ADVISORS, LLC 对 ANTX 的持仓历史

AN2 THERAPEUTICS INC · 医疗保健

ACORN CAPITAL ADVISORS, LLC 在 Q3 2026 的 13F 申报中披露持有 ANTX(AN2 THERAPEUTICS INC)1,300,000 股,市值约 US$6.9M,约占其申报组合的 1.90%,在其申报持仓中市值排名第 12 位。 ACORN CAPITAL ADVISORS, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.30M 股
申报持仓市值$6.92M
组合权重1.90%
首次申报Q3 2026
最近变动新进
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

ACORN CAPITAL ADVISORS, LLC 对 ANTX 的持仓演变

ACORN CAPITAL ADVISORS, LLC 于 Q3 2026 首次披露 ANTX 持仓:1,300,000 股(约 US$6.9M)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.30M $6.92M 新进

关于 ANTX 与 13F 数据

ANTX(AN2 THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 ANTX,申报仓位最大的包括:Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$9.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ANTX 的基金

查看 ANTX 的全部基金持有人 →

常见问题

How long has ACORN CAPITAL ADVISORS, LLC held ANTX?

ACORN CAPITAL ADVISORS, LLC has disclosed ANTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACORN CAPITAL ADVISORS, LLC's current position in ANTX?

As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 1.30M shares of ANTX (AN2 THERAPEUTICS INC), valued at $6.92M, representing 1.90% of its reported portfolio and ranking #12.

Has ACORN CAPITAL ADVISORS, LLC been buying or selling ANTX?

In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC newly opened its position in ANTX.

Which other funds hold ANTX?

Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.